These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2898602)

  • 1. Severe hypocalcaemia in AIDS patients treated with foscarnet and pentamidine.
    Youle MS; Clarbour J; Gazzard B; Chanas A
    Lancet; 1988 Jun; 1(8600):1455-6. PubMed ID: 2898602
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of Foscarnet therapy on infection with human immunodeficiency virus in patients with AIDS.
    Jacobson MA; Crowe S; Levy J; Aweeka F; Gambertoglio J; McManus N; Mills J
    J Infect Dis; 1988 Oct; 158(4):862-5. PubMed ID: 2844921
    [No Abstract]   [Full Text] [Related]  

  • 3. Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
    Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
    [No Abstract]   [Full Text] [Related]  

  • 4. Generalised cutaneous rash associated with foscarnet usage in AIDS.
    Green ST; Nathwani D; Goldberg DJ; Mack DJ; Kennedy DH
    J Infect; 1990 Sep; 21(2):227-8. PubMed ID: 2146323
    [No Abstract]   [Full Text] [Related]  

  • 5. Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
    Bergdahl S; Sönnerborg A; Larsson A; Strannegard O
    Lancet; 1988 May; 1(8593):1052. PubMed ID: 2896890
    [No Abstract]   [Full Text] [Related]  

  • 6. Foscarnet-induced acute renal failure and effectiveness of haemodialysis.
    Deray G; Cacoub P; Le Hoang P; Baumelou A; Soubrie C; Rousselie F; Morer I; Jacobs C
    Lancet; 1987 Jul; 2(8552):216. PubMed ID: 2885666
    [No Abstract]   [Full Text] [Related]  

  • 7. Generalised cutaneous rash associated with foscarnet usage in AIDS.
    Blanshard C
    J Infect; 1991 Nov; 23(3):336-7. PubMed ID: 1836487
    [No Abstract]   [Full Text] [Related]  

  • 8. Foscarnet and extended survival in AIDS patients.
    Am Fam Physician; 1991 Dec; 44(6):2244. PubMed ID: 1836090
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of Foscarnet in the treatment of cytomegalovirus pneumopathy in a patient with acquired immunodeficiency syndrome].
    Brochard L; Salmeron S; Herve P; Petitpretz P; Boissonnas A; Simonneau G; Duroux P
    Presse Med; 1986 Nov; 15(40):2022-3. PubMed ID: 3025830
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prophylactic treatments of opportunistic infections in acquired immunodeficiency syndrome].
    Longuet P; Leport C
    Ann Med Interne (Paris); 1992; 143(1):61-8. PubMed ID: 1534972
    [No Abstract]   [Full Text] [Related]  

  • 11. Foscarnet therapy in persons with AIDS: clinical research and management considerations. Introduction.
    Gazzard BG
    J Acquir Immune Defic Syndr (1988); 1992; 5 Suppl 1():S1-2. PubMed ID: 1534838
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of foscarnet (phosphonoformate) on human immunodeficiency virus isolation, T-cell subsets and lymphocyte function in AIDS patients.
    Gaub J; Pedersen C; Poulsen AG; Mathiesen LR; Ulrich K; Lindhardt BO; Faber V; Gerstoft J; Hofmann B; Lernestedt JO
    AIDS; 1987 May; 1(1):27-33. PubMed ID: 2962590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute renal failure induced by foscarnet: 4 cases.
    Cacoub P; Deray G; Baumelou A; Le Hoang P; Rozenbaum W; Gentilini M; Soubrie C; Rousselie R; Jacobs C
    Clin Nephrol; 1988 Jun; 29(6):315-8. PubMed ID: 2840226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Didanosine and foscarnet marketed for use by patients with AIDS.
    Clin Pharm; 1992 Jan; 11(1):4, 6. PubMed ID: 1309689
    [No Abstract]   [Full Text] [Related]  

  • 15. Foscarnet.
    Med Lett Drugs Ther; 1992 Jan; 34(861):3-4. PubMed ID: 1309469
    [No Abstract]   [Full Text] [Related]  

  • 16. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    Chatis PA; Miller CH; Schrager LE; Crumpacker CS
    N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
    [No Abstract]   [Full Text] [Related]  

  • 17. Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism.
    Jacobson MA; Gambertoglio JG; Aweeka FT; Causey DM; Portale AA
    J Clin Endocrinol Metab; 1991 May; 72(5):1130-5. PubMed ID: 1827127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS.
    Shah GM; Alvarado P; Kirschenbaum MA
    Am J Med; 1990 Sep; 89(3):380-2. PubMed ID: 2393042
    [No Abstract]   [Full Text] [Related]  

  • 19. Ventricular tachycardia due to pentamidine isethionate.
    Pujol M; Carratala J; Mauri J; Viladrich PF
    Am J Med; 1988 May; 84(5):980. PubMed ID: 3364459
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrine effects of HIV infection.
    Chakrabarti J
    N Engl J Med; 1993 Mar; 328(12):889-90. PubMed ID: 8441444
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.